Identification of Biomarkers for Patients with Vascular Anomalies

ConditionsVascular Anomaly Generalized Lymphatic Anomaly Kaposiform Hemangioendothelioma Kaposiform Lymphangiomatosis Gorham-Stout Disease Klippel Trenaunay Syndrome Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1+

SponsorChildren's Hospital Medical Center, Cincinnati

About this trial

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Eligibility criteria

Qualifiers

Any patient having labs drawn as standard of care will have blood drawn for the study if consented/ assented.

All patients who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank.

Disqualifiers

N/A

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations

Boston Children's Hospital02115, BostonMassachusetts, United States

Cincinnati Children's Hospital Medical Center45229, CincinnatiOhio, United States

Sponsors and collaborators

Children's Hospital Medical Center, Cincinnati

Lead sponsor

Lymphangiomatosis and Gorham's Disease Alliance (LGDA)

Collaborator

Klippel Trenaunay (KT) Support Group

Collaborator

CLOVES Syndrome Community Support Group

Collaborator

Source ClinicalTrials.gov